{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:45:34Z","timestamp":1761126334231},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1053\/bega.2000.0108","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"629-641","source":"Crossref","is-referenced-by-count":11,"title":["Management of osteoporosis in primary biliary cirrhosis"],"prefix":"10.1053","volume":"14","author":[{"given":"Frank H.J","family":"Wolfhagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk R","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P","family":"Vleggaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solko W","family":"Schalm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2000.0108_RF1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-1007365","article-title":"Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis","volume":"13","author":"Lindor","year":"1993","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2000.0108_RF2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0016-5085(95)90033-0","article-title":"Bone disease in cholestatic liver disease","volume":"108","author":"Hay","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0108_RF4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0016-5085(88)90438-6","article-title":"Metabolic bone disease in primary biliary cirrhosis at presentation","volume":"94","author":"Mitchison","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF5","first-page":"783","article-title":"Osteoporosis in chronic cholestatic liver disease","volume":"57","author":"Stellon","year":"1985","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF6","first-page":"1356","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis","volume":"85","author":"Gua\u00f1abens","year":"1990","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF7","first-page":"1462","article-title":"Bone disease in liver transplant recipients: incidence, timing, and risk factors","volume":"23","author":"Porayko","year":"1991","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0108_RF8","first-page":"47","article-title":"Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment","volume":"89","author":"Crippin","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF9","first-page":"389","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","volume":"21","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0108_RF10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gut.31.1.82","article-title":"Osteoporosis and skeletal fractures in chronic liver disease","volume":"31","author":"Diamond","year":"1990","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0108_RF11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840120214","article-title":"Prevalence and prediction of osteopenia in chronic liver disease","volume":"12","author":"Bonkovsky","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0108_RF12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0016-5085(89)90783-X","article-title":"Hepatic osteodystrophy","volume":"96","author":"Diamond","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(99)80167-6","article-title":"Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease","volume":"31","author":"Ormarsdottir","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0016-5085(90)90635-E","article-title":"Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids","volume":"99","author":"van Berkum","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","article-title":"Bone loss and reduced osteoblast function in primary biliary cirrhosis","volume":"103","author":"Hodgson","year":"1985","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0108_RF16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1989.tb00065.x","article-title":"Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis","volume":"225","author":"Almdal","year":"1989","journal-title":"Journal of Internal Medicine"},{"key":"10.1053\/bega.2000.0108_RF17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(94)90324-7","article-title":"Bone loss after orthotopic liver transplantation","volume":"97","author":"Meys","year":"1994","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0168-8278(88)80467-7","article-title":"Bone disease after orthotopic liver transplantation","volume":"6","author":"Haagsma","year":"1988","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3109\/00365529509101633","article-title":"Bone mineral status in end-stage liver disease and the effect of liver transplantation","volume":"30","author":"Abdelhadi","year":"1995","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hep.1840140407","article-title":"Bone loss after liver transplantation","volume":"14","author":"McDonald","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0108_RF21","first-page":"2709","article-title":"Bone disease after liver transplantation","volume":"24","author":"Arnold","year":"1992","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0108_RF22","first-page":"1738","article-title":"Bone loss after orthotopic liver transplantation: FK 507 versus cyclosporine","volume":"28","author":"Park","year":"1996","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0108_RF23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/lt.500050507","article-title":"Evidence of continuing bone recovery at a mean of 7 years after liver transplantation","volume":"4","author":"Feller","year":"1999","journal-title":"Liver Transplantation Surgery"},{"key":"10.1053\/bega.2000.0108_RF24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0168-8278(96)80243-1","article-title":"Early increase in plasma parathyroid hormone levels following liver transplantation","volume":"25","author":"Compston","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","article-title":"Osteoporosis and bone mineral metabolism disorders in cirrhotic partients referred for orthotopic liver transplantation","volume":"60","author":"Monegal","year":"1997","journal-title":"Calcified Tissue International"},{"key":"10.1053\/bega.2000.0108_RF26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/8756-3282(93)90310-7","article-title":"Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis","volume":"14","author":"Hodgson","year":"1993","journal-title":"Bone"},{"key":"10.1053\/bega.2000.0108_RF27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","article-title":"Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis","volume":"118","author":"Springer","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.15.10.788","article-title":"The relief of bone pain in primary biliary cirrhosis with calcium infusions","volume":"15","author":"Ajdukiewicz","year":"1974","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0108_RF29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajcn\/36.3.426","article-title":"Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis","volume":"36","author":"Epstein","year":"1982","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1053\/bega.2000.0108_RF32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","article-title":"Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment","volume":"83","author":"Matloff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s005350050250","article-title":"Calcitriol for bone loss in patients with primary biliary cirrhosis","volume":"34","author":"Shiomi","year":"1999","journal-title":"Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF02365443","article-title":"Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dual-energy X-ray absorptiometry","volume":"29","author":"Shiomi","year":"1994","journal-title":"Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1478-3231.1999.tb00034.x","article-title":"Estrogen\u2013progestogen therapy for low bone mineral density in primary biliary cirrhosis","volume":"19","author":"Olsson","year":"1999","journal-title":"Liver"},{"key":"10.1053\/bega.2000.0108_RF36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","article-title":"Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis","volume":"322","author":"Riggs","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01623313","article-title":"Histomorphometric analysis of iliac crest bone biopsies in placebo-treated vesus fluoride-treated subjects","volume":"5","author":"Lundy","year":"1995","journal-title":"Osteoporosis International"},{"key":"10.1053\/bega.2000.0108_RF38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01625446","article-title":"A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis","volume":"1","author":"Kleerekoper","year":"1991","journal-title":"Osteoporosis International"},{"key":"10.1053\/bega.2000.0108_RF39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-123-6-199509150-00001","article-title":"Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial","volume":"123","author":"Pak","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0108_RF40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0168-8278(92)90066-X","article-title":"Sodium fluoride prevents bone loss in primary biliary cirrhosis","volume":"15","author":"Gua\u00f1abens","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0016-5085(97)70098-2","article-title":"Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years","volume":"113","author":"Gua\u00f1abens","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF42","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis","volume":"322","author":"Storm","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","article-title":"Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy","volume":"95","author":"Harris","year":"1993","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0108_RF46","first-page":"472A","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"30","author":"Pares","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0108_RF47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","article-title":"Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis","volume":"20","author":"Camisasca","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0108_RF48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004836-199706000-00012","article-title":"A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis","volume":"24","author":"Floreani","year":"1997","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02555844","article-title":"Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled study","volume":"49","author":"Lyritis","year":"1991","journal-title":"Calcified Tissue International"},{"key":"10.1053\/bega.2000.0108_RF50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF51","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0168-8278(98)80254-7","article-title":"Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study","volume":"29","author":"Wolfhagen","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0108_RF54","series-title":"Diseases of the Liver and Biliary System","first-page":"237","article-title":"Primary biliary cirrhosis","author":"Sherlock","year":"1994"},{"key":"10.1053\/bega.2000.0108_RF55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0950-3579(05)80080-9","article-title":"Corticosteroid osteoporosis","volume":"7","author":"Reid","year":"1993","journal-title":"Bailli\u00e8re's Clinical Rheumatology"},{"key":"10.1053\/bega.2000.0108_RF56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-Q","article-title":"Bone loss in response to long-term glucocorticoid therapy","volume":"8","author":"LoCascio","year":"1990","journal-title":"Bone and Mineral"},{"key":"10.1053\/bega.2000.0108_RF57","first-page":"543","article-title":"Low-dose corticosteroids in chronic active hepatitis do not adversely affect spinal bone","volume":"5","author":"Clements","year":"1993","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0108_RF58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/ard.45.11.950","article-title":"Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids","volume":"45","author":"Sambrook","year":"1986","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1053\/bega.2000.0108_RF59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(97)80048-7","article-title":"Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis","volume":"26","author":"Wolfhagen","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0108_RF60","first-page":"1148","article-title":"A meta-analysis on the use of bisphosphonates in corticosteroid induced osteoporosis","volume":"26","author":"Homik","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/bega.2000.0108_RF61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/33.4.348","article-title":"Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss","volume":"33","author":"Mulder","year":"1994","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/bega.2000.0108_RF62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF64","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/bega.2000.0108_RF65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002239900709","article-title":"Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation","volume":"65","author":"Sambrook","year":"1999","journal-title":"Calcified Tissue International"},{"key":"10.1053\/bega.2000.0108_RF66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s002239900706","article-title":"Alphacalcidol in prevention of glucocorticoid-induced osteoporosis","volume":"65","author":"Reginster","year":"1999","journal-title":"Calcified Tissue International"},{"key":"10.1053\/bega.2000.0108_RF67","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin","volume":"328","author":"Sambrook","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0108_RF68","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00007890-199605270-00015","article-title":"Prevention of bone loss in cardiac transplant recipients: a comparison of bisphosphonates and vitamin D","volume":"61","author":"van Cleemput","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0108_RF69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02529727","article-title":"A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica","volume":"58","author":"Healey","year":"1996","journal-title":"Calcified Tissue International"},{"key":"10.1053\/bega.2000.0108_RF70","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/36.2.255","article-title":"Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis","volume":"36","author":"Adachi","year":"1997","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/bega.2000.0108_RF71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00610377","article-title":"Salmon calcitonin in the therapy of corticoid-induced osteoporosis","volume":"33","author":"Ringe","year":"1987","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1053\/bega.2000.0108_RF72","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/lt.500040508","article-title":"Intravenous bisphosphonate prevents osteoporotic vertebral collapse in patients after liver transplantation","volume":"4","author":"Reeves","year":"1998","journal-title":"Liver Transplantation and Surgery"},{"key":"10.1053\/bega.2000.0108_RF73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01622737","article-title":"Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol","volume":"6","author":"Riemens","year":"1996","journal-title":"Osteoporosis International"},{"key":"10.1053\/bega.2000.0108_RF74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00298990","article-title":"Calcitonin and bisphosphonate treatment in bone loss after liver transplantation","volume":"57","author":"Valero","year":"1995","journal-title":"Calcified Tissue International"},{"key":"10.1053\/bega.2000.0108_RF75","first-page":"635","article-title":"Antiresorptive therapy prevents bone loss after cardiac transplantation","volume":"11","author":"Shane","year":"1996","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1053\/bega.2000.0108_RF76","first-page":"A2714","article-title":"Randomized prospective study demonstrating prevention of bone loss by pamidronate during the first year after renal transplantation","volume":"7","author":"Fan","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1053\/bega.2000.0108_RF77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0041-1345(98)01713-8","article-title":"Calcitriol in prevention and therapy of osteoporosis after liver transplantation","volume":"31","author":"Neuhaus","year":"1999","journal-title":"Transplantation Proceedings"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800901082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800901082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T05:33:02Z","timestamp":1621143182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691800901082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S1521691800901082"],"URL":"https:\/\/doi.org\/10.1053\/bega.2000.0108","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}